Progyny (PGNY) Receivables (2018 - 2026)

Progyny (PGNY) has reported Receivables for 9 consecutive years, with $293.9 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Receivables fell 8.46% year-over-year to $293.9 million in Q2 2026; TTM through Jun 2026 was $293.9 million, a 8.46% decrease from a year earlier, with the FY2025 full-year figure at $254.2 million, down 9.97% from the prior year.
• Receivables was $293.9 million for Q2 2026 at Progyny, down from $299.0 million in the prior quarter.
• Over five years, Receivables peaked at $370.3 million in Q2 2024 and troughed at $229.4 million in Q1 2022.
• A 5-year average of $308.8 million and a median of $304.7 million in 2023 frame the typical range for Receivables.
• Across the five-year window, Receivables soared 102.36% in 2022 and decreased 16.51% in 2026, its largest moves.
• Over 5 years, Receivables stood at $283.0 million in 2022, then rose by 1.41% to $287.0 million in 2023, then dropped by 1.62% to $282.3 million in 2024, then slipped by 9.97% to $254.2 million in 2025, then rose by 15.61% to $293.9 million in 2026.
• The last three Receivables figures came in at $293.9 million (Q2 2026), $299.0 million (Q1 2026), and $254.2 million (Q4 2025), per Business Quant data.